Table 3.
Study | Year | Sample size | Mean followup (months) | Rate of medical complications | Mortality rate related to surgery or infection | Annualized reinfection rate | Overall reinfection rate | Failure rates for other reasons | Overall infection eradication success rate |
---|---|---|---|---|---|---|---|---|---|
Buchholz et al. [20] | 1981 | 640 | 52 | NM | 2.7% | 16% | 23% | 3.3% | 76.8% |
Wroblewski [99] | 1986 | 102 | 38 | NM | NM | 3% | 9% | NM | 91% |
Hope et al. [46] | 1989 | 72 | NM | NM | NM | NM | 13% | 3% | 87% |
Loty et al. [64] | 1992 | 90 | 47 | NM | 1.1% | 9% | 10% | 7.8% | 79% |
Elson [38] | 1994 | 235 | NM | NM | NM | NM | 14% | NM | 86% |
Raut et al. [83] | 1994 | 57 | 88 | 12.3% | 7% | 2% | 14% | 7% | 86% |
Raut et al. [82] | 1996 | 15 | 120 | NM | NM | 1% | 7% | 6.7% | 87% |
Ure et al. [94] | 1998 | 20 | 120 | NM | 0% | 0% | 0% | 10% | 100% |
Callaghan et al. [24] | 1999 | 24 | 120 | NM | NM | 1% | 8.3% | 4.2% | 92% |
Jackson & Schmalzried [49] | 2000 | 1299 | 58 | NM | 0.8% | 5% | 17% | NM | 83% |
Vielpeau & Lortat-Jacob [96] | 2002 | 127 | 36 | NM | NM | 12% | 16% | NM | 84% |
Rudelli et al. [86] | 2008 | 32 | 103 | NM | NM | 1% | 6.2% | 3.1% | 94% |
Wolf et al. [98] | 2011 | 576 | NM | NM | 0.5% | 12%* | 28% | 4.3% | 72% |
Beswick et al. [10] | 2012 | 1225 | 24 | NM | NM | 5% | 9% | NM | 91% |
Lange et al. [60] | 2012 | 375 | NM | NM | NM | NM | 13% | NM | 87% |
Zeller et al. [100] | 2014 | 157 | 41.6 | NM | 1.3% | 3% | 5% | 5.7% | 88% |
Kunutsor et al. [56] | 2015 | 2536 | 35 | NM | NM | 8% | 8% | NM | 92% |
Totals | 7582 | 67.8 | 5.1% | 12.4% | 5.5% | 87.5% |
Weighted annual reinfection rate 9.8%; * rate stated explicitly in study; NM = not mentioned.